@otc_slaps@johnneyyzhang@MrZackMorris That’s the point. I think $PTKN can justify a half-billion valuation, but Pink sheets don’t attract big money. Clean up the structure, improve reporting, and pursue an uplist so the bigger market can see it. That’s why I mentioned a possible RS not as the only path, but a tool
$PTKN Good RS = cleanup, uplist path, tighter structure, and no dilution after. $HITI, $DUOT, $CTSO, and $SRAX all used reverse splits/consolidations as part of an OTC-to-Nasdaq uplist path. $GMGI/ $MRDN is another recent example of structure cleanup/name-ticker reset for Nasdaq!
https://t.co/Vy0uyoHVOT
When cost becomes more important than results, we don’t become efficient — we become greedy. Money isn’t the problem. Priorities are. @elonmusk
@kirawontmiss Now he will have time to think before he acts. People defending monetary value over life lessons. I've seen too many problems come from gaming. If that game pissed him off enough to throw a cat then its deserved. Too many people are scared to hard parent. Parent 1st friend 2nd
@SenWarren We all win if we focused on actually curing diabetes instead of funding lifelong treatments that keep Big Pharma profitable year after year? Isn't there a smarter way to stop 'milking the cow dry'—by rewarding real cures and prevention over perpetual management?